MSC to chondrocyte mitochondrial transfer quantification

PRIMARY OUTCOME

quantification of mitochondrial transfer by flow cytometry

EXPECTED OUTCOMES

1. **Baseline transfer rate at 24h**: 12-18% of chondrocytes will display double-positive mitochondrial signal (MSC-derived Green + chondrocyte-derived Red), indicating active mitochondrial transfer via tunneling nanotubes. 2. **Time-dependent increase**: Mitochondrial transfer will increase linearly from 24h (15 ± 3%) to 72h (35 ± 5%), reaching 45 ± 7% at 168h (7 days), demonstrating sustained horizontal mitochondrial transfer. 3. **Transfer inhibition by Cytochalasin D**: Co-cultures treated with 10 μM Cytochalasin D will show ≥85% reduction in double-positive events at all timepoints (≤2.5% at 72h), confirming nanotube-mediated mechanism. 4. **OA model enhancement**: IL-1β/TNF-α treated chondrocytes co-cultured with MSCs will show 1.6-1.8× higher mitochondrial transfer rates compared to baseline conditions at day 7 (56 ± 8% vs 32 ± 4%). 5. **Functional improvement**: Co-cultured chondrocytes will exhibit 40-50% higher intracellular ATP levels compared to chondrocyte-only controls at day 7 (2.8 ± 0.3 nmol ATP/μg protein vs 1.9 ± 0.2 nmol ATP/μg protein). 6. **Anti-apoptotic effect**: Co-culture with MSCs will reduce chondrocyte apoptosis rates from 18 ± 3% (chondrocytes alone, OA condition) to 8 ± 2% (co-culture, OA condition) at day 7, as measured by Annexin V/PI. 7. **Inflammatory modulation**: Co-culture will reduce IL-6 secretion by 45-55% in OA chondrocyte cultures by day 7 (85 ± 15 pg/mL vs 180 ± 25 pg/mL in chondrocyte-only OA cultures).

SUCCESS CRITERIA

- **Primary endpoint**: Mitochondrial transfer quantified by flow cytometry shows ≥30% double-positive chondrocytes at 7 days in MSC-chondrocyte co-culture, with p < 0.001 (one-way ANOVA with Tukey's post-hoc test, n ≥ 6 independent experiments). - **Mechanistic validation**: Cytochalasin D treatment reduces transfer by ≥80% compared to vehicle control (DMSO), confirming tunneling nanotube dependence, with p < 0.01 (unpaired t-test, n = 4). - **OA model response**: Inflammatory cytokine treatment (IL-1β + TNF-α) enhances transfer by ≥1.5-fold compared to baseline conditions, with p < 0.01 (unpaired t-test, n = 5). - **Cellular functionality**: Co-cultured chondrocytes show ≥25% improvement in ATP production versus chondrocyte-only controls, with p < 0.05 (unpaired t-test, n = 6). - **Anti-apoptotic effect**: MSC co-culture reduces chondrocyte apoptosis by ≥40% under OA conditions, with p < 0.01 (unpaired t-test, n = 5). - **Effect size requirement**: Cohen's d ≥ 0.8 for all primary comparisons between co-culture and control conditions, indicating large effect sizes for biological significance. - **Reproducibility threshold**: All protocols will be validated across ≥3 independent donor MSC preparations and ≥2 independent chondrocyte passages, with coefficient of variation ≤25% for transfer metrics.

PROTOCOL

### Phase 1: Cell Culture & Preparation (Day 0) **Timepoint: 0 hours** - Thaw cryopreserved human bone marrow-derived MSCs (Lonza, cat# PT-2501) and immortalized human chondrocytes (TC28a2 line) according to manufacturer's protocols - Culture MSCs in MSCGM-CD BulletKit medium (Lonza, cat# PT-3001) at 37°C, 5% CO₂ on collagen I-coated flasks (Corning, cat# 354471) - Culture chondrocytes in DMEM/F-12 (Gibco, cat# 11330) supplemented with 10% FBS and 1% penicillin-streptomycin at 37°C, 5% CO₂ - Passage MSCs at 80% confluence (use cells P3-P5); passage chondrocytes at 80% confluence (use cells P10-P15) - Prior to co-culture, label MSCs with MitoTracker Green FM (Thermo Fisher, cat# M7514) at 200 nM in serum-free medium for 30 min at 37°C, then wash 3× with PBS - Label chondrocytes with MitoTracker Red CMXRos (Thermo Fisher, cat# M7512) at 100 nM in serum-free medium for 30 min at 37°C, then wash 3× with PBS - Validate mitochondrial labeling efficiency by imaging ( Zeiss Axio Observer) and flow cytometry (≥95% positive required) ### Phase 2: Co-Culture Setup (Day 0-1) **Timepoint: 0-24 hours** - Prepare transwell inserts (Corning, cat# 3460) with 0.4 μm pores allowing only soluble factor/mitochondrial vesicle passage - Seed 1×10⁵ labeled chondrocytes in the bottom chamber of a 12-well plate in chondrocyte culture medium - Seed 1×10⁵ MitoTracker Green-labeled MSCs in the transwell insert (MSC:chondrocyte ratio = 1:1) - Include controls: chondrocytes alone (no MSC), MSCs alone (no chondrocytes), and chondrocytes with 10 μM Cytochalasin D (Sigma, cat# C2618) to inhibit tunneling nanotube formation - Incubate at 37°C, 5% CO₂ for 24 hours for baseline mitochondrial transfer ### Phase 3: Time Course Assessment (Day 1-7) **Timepoints: 24h, 48h, 72h, 96h, 168h (7 days)** - At each timepoint, harvest chondrocytes by trypsinization (0.25% EDTA-free trypsin, Gibco, cat# 12605) for 5 min at 37°C - Centrifuge cells at 300×g for 5 min, resuspend in 200 μL FACS buffer (PBS + 2% FBS + 2 mM EDTA) - Fix cells with 4% paraformaldehyde (Electron Microscopy Sciences, cat# 15710) for 15 min at room temperature - Permeabilize with 0.1% Triton X-100 (Sigma, cat# X100) for 10 min for intracellular staining - Stain with anti-Tomm20-PE antibody (BD Biosciences, cat# 612278) at 1:50 dilution for mitochondrial identification - Include single-color controls for compensation: MitoTracker Green alone, MitoTracker Red alone, Tomm20-PE alone, and unstained cells ### Phase 4: Flow Cytometry Acquisition (Day 1-7) **Timepoints: Same as Phase 3** - Use BD LSRFortessa X-20 flow cytometer with 488 nm (Blue) and 561 nm (Yellow-Green) lasers - Acquire 50,000 events per sample at low flow rate (400 events/sec max) - Gating strategy: 1. FSC-A vs SSC-A to identify single cells 2. FSC-A vs FSC-H to doublet discrimination 3. Tomm20-PE positive gate (mitochondrial signal) 4. MitoTracker Green (MSC donor) vs MitoTracker Red (chondrocyte recipient) double-positive cells = mitochondrial transfer events - Analyze using FlowJo v10.8 software - Calculate transfer efficiency as: (% double-positive chondrocytes / total chondrocytes) × 100 ### Phase 5: Osteoarthritis Model Validation (Parallel Arms) **Timepoints: Day 0, 7, 14** - In separate wells, treat chondrocytes with 5 ng/mL IL-1β (R&D Systems, cat# 201-LB) + 10 ng/mL TNF-α (R&D Systems, cat# 210-TA) for 24h to simulate OA inflammatory environment - Compare mitochondrial transfer rates in OA-like conditions vs baseline - Measure intracellular ROS using CellROX Deep Red (Thermo Fisher, cat# C10422) at 5 μM for 30 min at 37°C - Measure mitochondrial membrane potential using JC-1 dye (Thermo Fisher, cat# M34152) according to manufacturer's protocol ### Phase 6: Functional Validation (Day 7-14) **Timepoints: Day 7, 14** - Assess chondrocyte survival by Annexin V/PI staining (Thermo Fisher, cat# V13241) via flow cytometry - Measure ATP production using CellTiter-Glo 2.0 assay (Promega, cat# G9241) - Perform Seahorse XF Real-Time ATP Rate Assay (Agilent, cat# 103592-100) to measure mitochondrial vs glycolytic ATP production - Collect conditioned media for ELISA measurements of inflammatory cytokines (IL-6, IL-8, TNF-α; R&D Systems, cat# D6050)

HTML iframe

<iframe src="http://scidex.ai/artifact/exp-608beb23-9ecc-4c7f-84ee-dd40abb6068b?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>

Markdown link

[MSC to chondrocyte mitochondrial transfer quantification](http://scidex.ai/artifact/exp-608beb23-9ecc-4c7f-84ee-dd40abb6068b)

Direct URL

http://scidex.ai/artifact/exp-608beb23-9ecc-4c7f-84ee-dd40abb6068b

Preview